Effect of omega-3 on treatment of hyperactive childre
Phase 2
- Conditions
- Attention deficit hyperactivity disorder (ADHD).Disturbance of activity and attention
- Registration Number
- IRCT2016050918927N2
- Lead Sponsor
- Medical University of Tabriz
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
children between 7-12 aged; ADHD diagnosis by expert pediatric psychology physician using DSM diagnosis index; No prevention for Omega-3 supplements; IQ index above 70; Without other psychology disorders; No intake of Omega-3 supplements since 2 months ago; Intake of methylphenidate tablet with a dose of 0.5-1 mg/kg/day as a medical treatment
Exclusion criteria:Stop the treatment by the child or parents; incorrect intake of the drug by the child; change the treatment method; Stop the treatment due to the side effects of the drug; Acute physical disease.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hyperactivity. Timepoint: Befor treatment and 6 weeks following end of treatment. Method of measurement: Score of Conners questionnaire.;Inattention. Timepoint: Befor treatment and 6 weeks following end of treatment. Method of measurement: Score of Conners questionnaire.;Impulsivity. Timepoint: Befor treatment and 6 weeks following end of treatment. Method of measurement: Score of Conners questionnaire.
- Secondary Outcome Measures
Name Time Method Abdominal pain. Timepoint: Befor treatment and 6 weeks following end of treatment. Method of measurement: Ritaline and omega-3 side effects questionnaire.;Diarrhea. Timepoint: Befor treatment and 6 weeks following end of treatment. Method of measurement: Ritaline and omega-3 side effects questionnaire.;Epistaxis. Timepoint: Befor treatment and 6 weeks following end of treatment. Method of measurement: Ritaline and omega-3 side effects questionnaire.